Judith M. Matthews, Chief Financial Officer at Iterum Therapeutics plc (ITRM), sold 67,736 shares at $1.73 ($117K) on 2021-01-26, disclosed to the SEC on 2021-01-27.
Open-market sale of $117k ITRM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.73 | 33,868 | $59K | 50.0% |
| 2 | $1.73 | 33,868 | $59K | 50.0% |
| Total | $1.73 avg | 67,736 | $117K | 100% |
| Filing → |
| ITRM | SELL | 2020-10-02 | $184K | — | Filing → |
| ITRM | BUY | 2018-05-30 | $52K | — | Filing → |